As of 2025-12-28, the Relative Valuation of Inovio Pharmaceuticals Inc (INO) is (38.71) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.29 USD, the upside of Inovio Pharmaceuticals Inc based on Relative Valuation is -1790.2%.
The range of the Relative Valuation is (34.74) - (39.33) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 22.0x - 25.0x | 24.6x |
| Forward P/E multiples | 22.1x - 29.4x | 24.6x |
| Fair Price | (34.74) - (39.33) | (38.71) |
| Upside | -1617.1% - -1817.7% | -1790.2% |
| Date | P/E |
| 2025-12-26 | -1.46 |
| 2025-12-24 | -1.43 |
| 2025-12-23 | -1.37 |
| 2025-12-22 | -1.43 |
| 2025-12-19 | -1.45 |
| 2025-12-18 | -1.51 |
| 2025-12-17 | -1.65 |
| 2025-12-16 | -1.47 |
| 2025-12-15 | -1.44 |
| 2025-12-12 | -1.31 |
| 2025-12-11 | -1.35 |
| 2025-12-10 | -1.38 |
| 2025-12-09 | -1.39 |
| 2025-12-08 | -1.33 |
| 2025-12-05 | -1.32 |
| 2025-12-04 | -1.28 |
| 2025-12-03 | -1.28 |
| 2025-12-02 | -1.22 |
| 2025-12-01 | -1.22 |
| 2025-11-28 | -1.31 |
| 2025-11-26 | -1.25 |
| 2025-11-25 | -1.15 |
| 2025-11-24 | -1.15 |
| 2025-11-21 | -1.12 |
| 2025-11-20 | -1.10 |
| 2025-11-19 | -1.13 |
| 2025-11-18 | -1.20 |
| 2025-11-17 | -1.26 |
| 2025-11-14 | -1.30 |
| 2025-11-13 | -1.24 |
| 2025-11-12 | -1.25 |
| 2025-11-11 | -1.27 |
| 2025-11-10 | -1.37 |
| 2025-11-07 | -1.35 |
| 2025-11-06 | -1.43 |
| 2025-11-05 | -1.46 |
| 2025-11-04 | -1.54 |
| 2025-11-03 | -1.59 |
| 2025-10-31 | -1.49 |
| 2025-10-30 | -1.50 |
| 2025-10-29 | -1.54 |
| 2025-10-28 | -1.64 |
| 2025-10-27 | -1.58 |
| 2025-10-24 | -1.48 |
| 2025-10-23 | -1.43 |
| 2025-10-22 | -1.41 |
| 2025-10-21 | -1.48 |
| 2025-10-20 | -1.57 |
| 2025-10-17 | -1.49 |
| 2025-10-16 | -1.56 |